Airain Ltd’s Medifast MED Stock Holding History

Airain Ltd’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-12,399	Closed	-$413K	–	728
2016 Q2	$413K	Buy	+12,399	New	+$400K	0.02%	476

Other funds holding MED

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Airain Ltd's MED Position: Q3 2016 in Review

Airain Ltd sold out of Medifast (MED) in Q3 2016, closing a stake of 12,399 shares — an estimated $413K sold.

Airain Ltd first reported a position in MED in Q2 2016 and held it in 1 quarter. The position peaked at $413K in Q2 2016. 165 funds tracked by Wall St. Rank hold MED as of Q3 2016.

Airain Ltd reported no remaining Medifast position as of Q3 2016 after selling out during the quarter.
Airain Ltd sold 12,399 Medifast shares in Q3 2016, an estimated $413K.
Airain Ltd first reported a position in Medifast in Q2 2016 and held it in 1 quarter.
Airain Ltd's Medifast position peaked at $413K in Q2 2016.
165 funds tracked by Wall St. Rank held Medifast as of Q3 2016.

Based on Airain Ltd's 13F filing for Q3 2016, filed 8 Nov 2016.